The first Ibuprofen Soft Capsules of the Company was approved for the Abbreviated New Drug Application (ANDA) by FDA on June 21,2016. In addition, over the past three years since the first product with ANDA was approved, the products of the Company including Dutasteride Soft Capsules, Naproxen Sodium Soft Capsules, Benzonatate Soft Capsules and Vitamin D2 Soft Capsules have been approved successively. PuraCap is equipped with 10 production lines including one progesterone line, 5 packaging lines and annual capacity reaches 8,000,000,000 pcs.
Provide products that satisfy the consistency evaluation;
Provide generic drugs with first-line high-end brand.